Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New scan aims to spot hidden bladder cancer spread

NCT ID NCT04018053

Summary

This study is testing a new type of PET scan to see if it can more accurately show how far muscle-invasive bladder cancer has spread, compared to the standard CT or MRI scans used today. The scan uses a special imaging agent called 18F-fluciclovine, which may help doctors see cancer near the bladder that other scans sometimes miss. The goal is to improve surgical planning by giving doctors a clearer picture of the cancer's extent before a patient undergoes major surgery to remove the bladder.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Dana Farber Cancer Institute

    Boston, Massachusetts, 02115, United States

Conditions

Explore the condition pages connected to this study.